From: Assessment of sleep quality, anxiety, depression, and quality of life in Behçet’s disease
PSQI | Behçet’s disease N = 30 | Control Group N = 30 | P-value |
---|---|---|---|
Sleep Quality | 1.77 ± 1.073 | 0.33 ± 0.479 | < 0.001* |
Sleep onset latency | 1.97 ± 1.299 | 0.3 ± 0.702 | < 0.001* |
Sleep duration | 1.63 ± 1.098 | 0.5 ± 0.731 | 0.001* |
Sleep efficiency | 1.7 ± 0.837 | 0.37 ± 0.049 | 0.010* |
Sleep disturbance | 1.13 ± 0.819 | 0.13 ± 0.346 | < 0.001* |
Sleep medications | 0.2 ± 0.551 | 0.0 ± 0.0 | < 0.001* |
Daytime dysfunction | 1.1 ± 0.759 | 0.13 ± 0.346 | < 0.001* |
PSQI global score | 9.17 ± 4.31 | 1.77 ± 1.97 | < 0.001* |